Lupus Foundation Provides Patient Perspective in ICER Drug Assessment
Sydney Otomancek2021-06-02T21:30:34-04:00June 2nd, 2021|Categories: Featured, Industry News|Tags: drugcosts, HEOR, ICER, lupus nephritis, pricing|
The Institute for Clinical and Economic Review (ICER) reviewed two drugs (voclosporin and belimumab) for use in cases of lupus [...]
Draft Scoping Document on Lupus Nephritis Posted by ICER
Sydney Otomancek2020-09-01T11:59:38-04:00September 1st, 2020|Categories: Featured, Industry News|Tags: healthcare, HEOR, ICER, lupus nephritis, scoping review|
In a draft scoping document, the Institute for Clinical and Economic Review (ICER) outlined plans to review the comparative clinical [...]
Receive essential insights, resources and content direct to your inbox!
Hit subscribe to stay informed!
Advertisement
Latest News
Featured Webinars
Navigating the Clinical Outcomes Maze: An Overview of Clinical Outcomes Assessments and Why Training Matters
Tuesday, December 5, 2023
Sponsor: ICON
EU HTA Joint Clinical Assessments: Navigating Potential Challenges Ahead of 2025
Friday, November 10, 2023
Sponsor: OpenHealth
Cell & Gene Therapies – Beginning with the End in Mind
Thursday, November 2, 2023
Sponsor: Magnolia Market Access
Categories
Artificial Intelligence
Careers
Clinical Trials
Cost Effectiveness
Data Analytics & Syndicated Reports
Healthcare Financing
Health Databases
Health Equity
Health Policy
Health Tech Assessment
Integrated Evidence Assessment & Planning
Market Access
Medical Affairs
Patient Outcomes & Engagement
Pricing & Reimbursement
Real World Data
Real World Evidence
Value Assessment
Value Communication